Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.
暂无分享,去创建一个
E. Oki | Y. Maehara | Y. Sakamoto | H. Saeki | Y. Ogata | Y. Akagi | H. Baba | Takaho Tanaka | Y. Miyamoto | S. Tokunaga | M. Shimokawa | Y. Emi